Suppr超能文献

美国计算机断层扫描(CT)和磁共振成像(MRI)的采用与普及:一项比较分析

The adoption and diffusion of CT and MRI in the United States. A comparative analysis.

作者信息

Hillman A L, Schwartz J S

出版信息

Med Care. 1985 Nov;23(11):1283-94. doi: 10.1097/00005650-198511000-00007.

Abstract

This study examines and compares the rates and patterns of diffusion of computerized tomography (CT) and magnetic resonance imaging (MRI) over the first 4 years of their availability. Although early diffusion of CT was more rapid than that of MRI, adoption of MRI in nonhospital settings equaled that of CT. Analysis of attributes of the technologies and attributes of the regulatory, reimbursement, and market environments surrounding the early diffusion of these technologies provides insight into their different diffusion patterns. In particular, the technical and financial uncertainties surrounding MRI have inhibited its diffusion compared with that of CT. Medicare's DRG-based prospective reimbursement system and certificate-of-need (CON) regulation by states have reduced overall MRI diffusion and stimulated purchases of MRI by nonhospital organizations. The FDA's premarket approval (PMA) program has changed marketing strategies and influenced the diffusion of MRI to a lesser degree. This analysis identifies problems in how the present health care system evaluates and adopts new, expensive, diagnostic technologies and suggests changes to make the system more responsive to present needs.

摘要

本研究考察并比较了计算机断层扫描(CT)和磁共振成像(MRI)在其可用的头4年中的扩散速率和模式。尽管CT的早期扩散比MRI更快,但MRI在非医院环境中的采用率与CT相当。对这些技术的属性以及围绕这些技术早期扩散的监管、报销和市场环境的属性进行分析,有助于深入了解它们不同的扩散模式。特别是,与CT相比,围绕MRI的技术和财务不确定性抑制了其扩散。医疗保险基于诊断相关组(DRG)的前瞻性报销系统以及各州的需求证明(CON)监管降低了MRI的总体扩散率,并刺激了非医院组织对MRI的购买。美国食品药品监督管理局(FDA)的上市前批准(PMA)计划改变了营销策略,并在较小程度上影响了MRI的扩散。该分析确定了当前医疗保健系统在评估和采用新的、昂贵的诊断技术方面存在的问题,并提出了使该系统更能响应当前需求的变革建议。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验